- Home
- KSCP vs SNTI Comparison
KSCP vs SNTI Comparison
Compare KSCP & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KSCP
- SNTI
- Stock Information
- Founded
- KSCP 2013
- SNTI 2016
- Country
- KSCP United States
- SNTI United States
- Employees
- KSCP N/A
- SNTI N/A
- Industry
- KSCP Telecommunications Equipment
- SNTI Biotechnology: Pharmaceutical Preparations
- Sector
- KSCP Telecommunications
- SNTI Health Care
- Exchange
- KSCP Nasdaq
- SNTI Nasdaq
- Market Cap
- KSCP 46.4M
- SNTI 39.6M
- IPO Year
- KSCP 2022
- SNTI N/A
- Fundamental
- Price
- KSCP $5.45
- SNTI $1.35
- Analyst Decision
- KSCP Strong Buy
- SNTI Strong Buy
- Analyst Count
- KSCP 3
- SNTI 2
- Target Price
- KSCP $17.00
- SNTI $8.50
- AVG Volume (30 Days)
- KSCP 368.0K
- SNTI 136.3K
- Earning Date
- KSCP 08-12-2025
- SNTI 08-07-2025
- Dividend Yield
- KSCP N/A
- SNTI N/A
- EPS Growth
- KSCP N/A
- SNTI N/A
- EPS
- KSCP N/A
- SNTI N/A
- Revenue
- KSCP $11,014,000.00
- SNTI N/A
- Revenue This Year
- KSCP $11.16
- SNTI N/A
- Revenue Next Year
- KSCP $34.72
- SNTI $150.00
- P/E Ratio
- KSCP N/A
- SNTI N/A
- Revenue Growth
- KSCP N/A
- SNTI N/A
- 52 Week Low
- KSCP $2.45
- SNTI $1.31
- 52 Week High
- KSCP $28.57
- SNTI $16.94
- Technical
- Relative Strength Index (RSI)
- KSCP 44.00
- SNTI 27.94
- Support Level
- KSCP $5.35
- SNTI $1.38
- Resistance Level
- KSCP $6.43
- SNTI $1.47
- Average True Range (ATR)
- KSCP 0.40
- SNTI 0.09
- MACD
- KSCP 0.01
- SNTI 0.00
- Stochastic Oscillator
- KSCP 31.05
- SNTI 10.29
About KSCP Knightscope Inc.
Knightscope Inc is a security technology company based in Silicon Valley. It designs, develops, manufactures, markets, and supports Autonomous Security Robots (ASRs), autonomous charging stations, the proprietary Knightscope Security Operations Center software user interface, Emergency Communication Devices platform with real-time on-site data collection and analysis and a proprietary interface for both indoor and outdoor usage. In addition, it developed and operates the Knightscope Security Operations Center (KSOC) which allows real-time data access, a service accessible to all its clients.
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.